Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,301 to 1,320 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of somatic mutations on prognosis in resected non-small-cell lung cancer: The Japan Molecular Epidemiology for lung cancer study. | Cancer Med | 2020 | 32022477 | PubTator, text mining | PubMed |
| The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer. | Lung Cancer (Auckl) | 2020 | 32021524 | PubTator, text mining | PubMed |
| Role of downregulated ADARB1 in lung squamous cell carcinoma. | Mol Med Rep | 2020 | 32016472 | PubTator, text mining | PubMed |
| Hsp47 promotes cancer metastasis by enhancing collagen-dependent cancer cell-platelet interaction. | Proc Natl Acad Sci U S A | 2020 | 32015106 | PubTator, text mining | PubMed |
| Angiotensin-II-Evoked Ca2+ Entry in Murine Cardiac Fibroblasts Does Not Depend on TRPC Channels. | Cells | 2020 | 32013125 | PubTator, text mining | PubMed |
Knockdown of Long Non-Coding RNA (lncRNA) Colon Cancer-Associated Transcript-1 (CCAT1) Suppresses Oral Squamous Cell Carcinoma Proliferation, Invasion, and Migration by Inhibiting the Discoidin Domain Receptor 2 (DDR2)/ERK/AKT Axis. | Med Sci Monit | 2020 | 32009633 | PubTator, text mining | PubMed |
| PGC1α suppresses kidney cancer progression by inhibiting collagen-induced SNAIL expression. | Matrix Biol | 2020 | 31982456 | PubTator, text mining | PubMed |
Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology. | Int J Clin Oncol | 2020 | 31974683 | PubTator, text mining | PubMed |
| Precision medicine for gastrointestinal cancer: Recent progress and future perspective. | World J Gastrointest Oncol | 2020 | 31966910 | PubTator, text mining | PubMed |
| Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis. | J Clin Med | 2020 | 31963850 | PubTator, text mining | PubMed |
| High Genetic Diversity and No Evidence of Clonal Relation in Synchronous Thyroid Carcinomas Associated with Hashimoto's Thyroiditis: A Next-Generation Sequencing Analysis. | Diagnostics (Basel) | 2020 | 31963551 | PubTator, text mining | PubMed |
| Cell-Surface Proteomic Profiling in the Fly Brain Uncovers Wiring Regulators. | Cell | 2020 | 31955847 | PubTator, text mining | PubMed |
| Whole Genome Sequencing of Spontaneously Occurring Rat Natural Killer Large Granular Lymphocyte Leukemia Identifies JAK1 Somatic Activating Mutation. | Cancers (Basel) | 2020 | 31947841 | PubTator, text mining | PubMed |
| Discovery of VU6015929: A Selective Discoidin Domain Receptor 1/2 (DDR1/2) Inhibitor to Explore the Role of DDR1 in Antifibrotic Therapy. | ACS Med Chem Lett | 2020 | 31938459 | PubTator, text mining | PubMed |
| Molecular profiling for precision cancer therapies. | Genome Med | 2020 | 31937368 | PubTator, text mining | PubMed |
| Molecular diagnostic characteristics based on the next generation sequencing in lung cancer and its relationship with the expression of PD-L1. | Pathol Res Pract | 2020 | 31926773 | PubTator, text mining | PubMed |
| Implementation and use of whole exome sequencing for metastatic solid cancer. | EBioMedicine | 2020 | 31923800 | PubTator, text mining | PubMed |
| The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design. | J Natl Cancer Inst | 2020 | 31922567 | PubTator, text mining | PubMed |
| Chain alignment of collagen I deciphered using computationally designed heterotrimers. | Nat Chem Biol | 2020 | 31907373 | PubTator, text mining | PubMed |
| Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy. | Theranostics | 2020 | 31903155 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=66